Archives

by in
Entry Author Date Location
Cell Therapeutics Shells Out $30M for New Drug 04/19/12 Seattle
Cell Therapeutics Stock Rises on EU Recommendation for Lymphoma Drug 02/17/12 Seattle
Cell Therapeutics Pulls FDA Application, Saying It Isn’t Ready For Panel 01/30/12 Seattle
The Year in Seattle Biotech: Lots of Acquisitions, Few New Startups 12/22/11 Seattle
Theraclone Nabs Big Pfizer Deal, Dendreon Pockets $540M, Seattle Genetics’ Close-Up, & More Seattle-Area Life Sciences News 01/20/11 Seattle
Cell Therapeutics Snags $25M 01/13/11 Seattle
Cell Therapeutics Seeks EU Approval 11/01/10 Seattle
Intellectual Ventures’ Med-Tech Foray, PATH Takes Ultra Rice to Africa, Mirador Gets FDA OK, & More Seattle-Area Life Sciences News 10/21/10 Seattle
Cell Therapeutics Adds $21M 10/20/10 Seattle
Lee Hartwell’s Next Career Move, Swedish’s Social Media Ace, Cell Therapeutics’ Lifeline, & More Seattle-Area Life Sciences News 09/23/10 Seattle
Cell Therapeutics Finds Way to Survive, Persuading Investors to OK Sale of 400M Shares 09/16/10 Seattle
Biotech Drug Discovery in Seattle: A Look Back 06/11/10 Seattle
Seattle Genetics Grows Up Fast, Valocor Seeks to Fight Acne, Cell Therapeutics Nabs $21M & More Seattle-Area Life Sciences News 05/27/10 Seattle
Cell Therapeutics Adds $21M 05/24/10 Seattle
AVI Biopharma Ousts CEO, CombiMatrix Drops Seattle Wing, Cell Therapeutics Cans 36 Workers, & More Seattle-Area Life Sciences News 04/22/10 Seattle
Cell Therapeutics Cuts 36 Employees 04/15/10 Seattle
Dendreon’s Pricing Question, UW’s $300M Stimulus Windfall, Cell Therapeutics Rejected by FDA, & More Seattle-Area Life Sciences News 04/15/10 Seattle
Cell Therapeutics Shareholder Meeting Postponed, After FDA Rejection 04/09/10 Seattle
Cell Therapeutics Lymphoma Drug Fails to Win FDA Approval 04/09/10 Seattle
Our Top 20 Stories of the First Quarter: Amazon, Cell Therapeutics, Dendreon, Microsoft, and More 04/02/10 Seattle
FDA Panel Slams Cell Therapeutics, Oncothyreon Slumps, Biotech’s Healthcare Victory, & More Seattle-Area Life Sciences News 03/25/10 Seattle
Cell Therapeutics Looks to Pick up the Pieces After FDA Smacks Down Lymphoma Drug 03/23/10 Seattle
Cell Therapeutics Shares Crash as Lymphoma Drug Gets Shot Down by FDA Panel 03/22/10 Seattle
FDA Cancer Drug Boss Slams Cell Therapeutics Application For Lymphoma Drug 03/22/10 Seattle
Cell Therapeutics FDA Panel Primer: Take Two 03/19/10 Seattle
Cell Therapeutics Passes Factory Test 03/08/10 Seattle
Cell Therapeutics Offers Execs Big Cash Bonuses As Stock Trades Below a Buck 03/05/10 Seattle
The Pharmaceutical R&D Model is Broken. Here’s How to Fix It 03/05/10 Seattle
Dendreon’s False Rumor, Cell Therapeutics’ New FDA Day, Microsoft’s Health-IT Plan, & More Seattle-Area Life Sciences News 03/04/10 Seattle
Cell Therapeutics Gets New Day in Front of FDA 03/01/10 Seattle
Page 1 of 4 next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Nine Lessons for Innovators from a Nobel Prize-Winning Psychologist
  2. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  3. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  4. Zillions of Biotech Conferences Want You. Which Should You Attend?
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.